Reuters logo
BRIEF-CRISPR Therapeutics announces patent for CRISPR/CAS genome editing in china
2017年6月19日 / 中午11点38分 / 3 个月前

BRIEF-CRISPR Therapeutics announces patent for CRISPR/CAS genome editing in china

June 19 (Reuters) - CRISPR Therapeutics AG:

* CRISPR Therapeutics announces patent for CRISPR/CAS genome editing in China

* CRISPR Therapeutics AG - China’s state intellectual property office granted a patent broadly covering CRISPR’s in-licensed gene editing technology Source text for Eikon: Further company coverage:

我们的标准汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below